in clinical trials Patient recruitment for moderate or severe atopic dermatitis Digital screening techniques for atopic dermatitis Understanding how digital patient recruitment and pre-screening ...

A long-running partnership between digital therapeutics (DTx ... as a treatment for moderate-to-severe atopic dermatitis in adults who cannot get relief from other therapies.

Rezpegaldesleukin is currently being investigated in the phase 2b REZOLVE-AD study (ClinicalTrials.gov Identifier: NCT06136741) in 398 adult patients with moderate to severe atopic dermatitis who ...

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...